ArticleHaematologica2023

Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival.

Maymona G Abdelmagid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.